DUSP5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.55250257094508E-11
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.489600E-02
Normal-vs-Stage2
3.01100255839515E-11
Normal-vs-Stage3
7.082200E-01
Normal-vs-Stage4
3.030400E-01
Stage1-vs-Stage2
1.652300E-02
Stage1-vs-Stage3
1.622560E-01
Stage1-vs-Stage4
7.113600E-01
Stage2-vs-Stage3
7.895900E-03
Stage2-vs-Stage4
7.070000E-01
Stage3-vs-Stage4
3.455200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.70390426399581E-11
Normal-vs-AfricanAmerican
1.101770E-01
Normal-vs-Asian
4.292400E-02
Caucasian-vs-AfricanAmerican
2.947400E-01
Caucasian-vs-Asian
5.566000E-01
AfricanAmerican-vs-Asian
2.298200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.55110000013659E-07
Normal-vs-Female
4.93609999541178E-08
Male-vs-Female
7.496200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.971400E-01
Normal-vs-Age(41-60Yrs)
1.71909999568953E-08
Normal-vs-Age(61-80Yrs)
1.70277999999024E-05
Normal-vs-Age(81-100Yrs)
2.599600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.705200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.650440E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.733800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.864100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.560420E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.884400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.067570E-02
Normal-vs-Daily Drinker
1.749610E-02
Normal-vs-Weekly Drinker
3.474200E-02
Normal-vs-Occasional Drinker
3.400400E-03
Normal-vs-Social Drinker
1.405710E-02
Non Drinker-vs-Daily Drinker
5.020200E-01
Non Drinker-vs-Weekly Drinker
8.094400E-01
Non Drinker-vs-Occasional Drinker
4.516400E-01
Non Drinker-vs-Social Drinker
3.616800E-01
Daily Drinker-vs-Weekly Drinker
3.935200E-01
Daily Drinker-vs-Occasional Drinker
9.997200E-01
Daily Drinker-vs-Social Drinker
1.790380E-01
Weekly Drinker-vs-Occasional Drinker
3.261000E-01
Weekly Drinker-vs-Social Drinker
5.541200E-01
Occasional Drinker-vs-Social Drinker
9.370300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.326800E-01
Normal-vs-Grade 2
3.409800E-01
Normal-vs-Grade 3
4.090600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.087800E-01
Grade 1-vs-Grade 3
1.512170E-01
Grade 1-vs-Grade 4
6.326800E-01
Grade 2-vs-Grade 3
2.611600E-01
Grade 2-vs-Grade 4
3.409800E-01
Grade 3-vs-Grade 4
4.090600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.76859999999812E-05
Normal-vs-NonDiabetic
5.71630000001377E-08
Diabetic-vs-NonDiabetic
4.534800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.981900E-03
Normal-vs-NoPancreatitis
1.37260000032668E-08
Pancreatitis-vs-NoPancreatitis
1.014210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.584960E-04
Normal-vs-N1
1.83009996046479E-09
N0-vs-N1
5.788800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.988600E-01
Normal-vs-TP53-NonMutant
8.600400E-01
TP53-Mutant-vs-TP53-NonMutant
1.245590E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
